FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130170286> ?p ?o ?g. }

• W2130170286 abstract "Botulinum neurotoxin A (BoNT-A) is a highly neurotoxic drug and frequently used in patients. Knowledge on the optimal way of administration of BoNT-A and its subsequent distribution is still rather limited. An accurate method for monitoring these processes might be the use of radiolabelled BoNT-A. In this paper, we report our feasibility study on labelling BoNT-A with high-dose iodine-125 (125I) via IODOGEN-coated BoNT-A method. Using cetuximab as model substrate for BoNT-A, a miniaturization of the IODOGEN-coated mAb method was developed with special attention to the minimum required amount of the oxidant IODOGEN, while the amount of substrate, reaction volume and reaction time were downsized. Labelling efficiency and radiochemical purity were determined by TLC, integrity by SDS-PAGE and HPLC and immunoreactivity by cell-binding assay. BoNT-A (50 μg) was labelled with 125I by coating with 2.5 μg IODOGEN, in a total reaction volume of 250 μL and a reaction time of 90 s. 125I-BoNT-A was purified by size exclusion chromatography (PD10 column) using ascorbic acid solution (5 mg/ml, pH = 5) as eluent. Quality analysis of 125I-BoNT-A was performed by an in vitro bladder strip model, an electrochemiluminescence assay and an Endopep assay. Cetuximab (50 μg) labelling with 125I (15 to 150 MBq) resulted in a labelling efficiency of 70% to 80%, a radiochemical purity of >99%, an immunoreactivity of >95% and a retained integrity on SDS; HPLC analysis revealed partly affected integrity when 110 to 150 MBq 125I was used, i.e. when the averaged I/mAb molar ratio exceeded 3. Addition of HEPES (20 mM) and lactose (1.25%) (lyophilized BoNT-A contains HEPES and lactose) decreased the labelling efficiency to 44% to 54%. BoNT-A (50 μg) labelling with 125I (97.2 to 98.3 MBq) resulted in labelling efficiency of 51% to 52% with a radiochemical purity >98.5%, a specific activity of 150.5 to 152.9 MBq/nmol and an I/BoNT-A molar ratio of 1.86 to 1.90. The in vitro bladder strip model showed no bioactivity of 125I-BoNT-A when compared to unlabelled BoNT-A. The electrochemiluminescence and Endopep assay demonstrated around 10% and 15% bioactivity of 125I-BoNT-A compared to unlabelled BoNT-A, respectively. The remaining bioactivity correlates within the Poisson distribution with the amount of BoNT-A molecules that does not bear an iodine atom. BoNT-A was successfully radio-iodinated with an activity high enough to enable in vivo measurement of nanograms of BoNT-A, which could be used in studying optimization of administration techniques of BoNT-A. The bioactivity of a BoNT-A molecule is, however, lost upon the introduction of an iodine atom into the tyrosine moiety of this sensitive molecule." @default.
• W2130170286 created "2016-06-24" @default.
• W2130170286 creator A5014924256 @default.
• W2130170286 creator A5018481009 @default.
• W2130170286 creator A5021862986 @default.
• W2130170286 creator A5027884050 @default.
• W2130170286 creator A5065849580 @default.
• W2130170286 creator A5086808752 @default.
• W2130170286 date "2015-02-19" @default.
• W2130170286 modified "2023-10-12" @default.
• W2130170286 title "The ultimate radiochemical nightmare: upon radio-iodination of Botulinum neurotoxin A, the introduced iodine atom itself seems to be fatal for the bioactivity of this macromolecule" @default.
• W2130170286 cites W1578011271 @default.
• W2130170286 cites W1843766617 @default.
• W2130170286 cites W1947863176 @default.
• W2130170286 cites W1964702786 @default.
• W2130170286 cites W1978197740 @default.
• W2130170286 cites W1984109801 @default.
• W2130170286 cites W2039820935 @default.
• W2130170286 cites W2044080354 @default.
• W2130170286 cites W2048449730 @default.
• W2130170286 cites W2051448097 @default.
• W2130170286 cites W2058426435 @default.
• W2130170286 cites W2062168648 @default.
• W2130170286 cites W2105833524 @default.
• W2130170286 cites W2120290278 @default.
• W2130170286 cites W2129922868 @default.
• W2130170286 cites W2141205142 @default.
• W2130170286 cites W2160387650 @default.
• W2130170286 cites W2166149942 @default.
• W2130170286 cites W2806696721 @default.
• W2130170286 cites W4232879147 @default.
• W2130170286 cites W4241019103 @default.
• W2130170286 doi "https://doi.org/10.1186/s13550-015-0083-5" @default.
• W2130170286 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4728162" @default.
• W2130170286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26812911" @default.
• W2130170286 hasPublicationYear "2015" @default.
• W2130170286 type Work @default.
• W2130170286 sameAs 2130170286 @default.
• W2130170286 citedByCount "6" @default.
• W2130170286 countsByYear W21301702862016 @default.
• W2130170286 countsByYear W21301702862018 @default.
• W2130170286 countsByYear W21301702862021 @default.
• W2130170286 countsByYear W21301702862022 @default.
• W2130170286 crossrefType "journal-article" @default.
• W2130170286 hasAuthorship W2130170286A5014924256 @default.
• W2130170286 hasAuthorship W2130170286A5018481009 @default.
• W2130170286 hasAuthorship W2130170286A5021862986 @default.
• W2130170286 hasAuthorship W2130170286A5027884050 @default.
• W2130170286 hasAuthorship W2130170286A5065849580 @default.
• W2130170286 hasAuthorship W2130170286A5086808752 @default.
• W2130170286 hasBestOaLocation W21301702861 @default.
• W2130170286 hasConcept C178790620 @default.
• W2130170286 hasConcept C185592680 @default.
• W2130170286 hasConcept C2777010668 @default.
• W2130170286 hasConcept C2777367657 @default.
• W2130170286 hasConcept C2780523633 @default.
• W2130170286 hasConcept C43617362 @default.
• W2130170286 hasConcept C51724486 @default.
• W2130170286 hasConcept C539932907 @default.
• W2130170286 hasConcept C55493867 @default.
• W2130170286 hasConcept C71924100 @default.
• W2130170286 hasConceptScore W2130170286C178790620 @default.
• W2130170286 hasConceptScore W2130170286C185592680 @default.
• W2130170286 hasConceptScore W2130170286C2777010668 @default.
• W2130170286 hasConceptScore W2130170286C2777367657 @default.
• W2130170286 hasConceptScore W2130170286C2780523633 @default.
• W2130170286 hasConceptScore W2130170286C43617362 @default.
• W2130170286 hasConceptScore W2130170286C51724486 @default.
• W2130170286 hasConceptScore W2130170286C539932907 @default.
• W2130170286 hasConceptScore W2130170286C55493867 @default.
• W2130170286 hasConceptScore W2130170286C71924100 @default.
• W2130170286 hasIssue "1" @default.
• W2130170286 hasLocation W21301702861 @default.
• W2130170286 hasLocation W21301702862 @default.
• W2130170286 hasLocation W21301702863 @default.
• W2130170286 hasLocation W21301702864 @default.
• W2130170286 hasLocation W21301702865 @default.
• W2130170286 hasOpenAccess W2130170286 @default.
• W2130170286 hasPrimaryLocation W21301702861 @default.
• W2130170286 hasRelatedWork W1501038299 @default.
• W2130170286 hasRelatedWork W1987309031 @default.
• W2130170286 hasRelatedWork W1989130613 @default.
• W2130170286 hasRelatedWork W1992938377 @default.
• W2130170286 hasRelatedWork W2008027106 @default.
• W2130170286 hasRelatedWork W2038524681 @default.
• W2130170286 hasRelatedWork W2058255727 @default.
• W2130170286 hasRelatedWork W2130170286 @default.
• W2130170286 hasRelatedWork W2228761597 @default.
• W2130170286 hasRelatedWork W1895489098 @default.
• W2130170286 hasVolume "5" @default.
• W2130170286 isParatext "false" @default.
• W2130170286 isRetracted "false" @default.
• W2130170286 magId "2130170286" @default.
• W2130170286 workType "article" @default.